{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-001796","form_type":"8-K","ticker":"BLGO","cik":"0000880242","company_name":"BIOLARGO, INC.","filed_at":"2024-01-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.118956+00:00","generated_at":"2026-06-06T20:53:40.883187+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"BioLargo Doubles Annual Revenues for Second Consecutive Year in 2023","bullets":["2023 annual revenues more than doubled 2022, driven by Pooph pet odor control product sales.","Pooph sold through Amazon, Walmart, Chewy; BioLargo is technology partner to Pooph, Inc.","Expects first PFAS treatment technology revenues in 2024 after securing a municipal drinking water project.","Preliminary 2023 revenue estimates subject to audit; annual report expected by end of March."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-001796","json":"https://secwatch.observer/filing/0001437749-24-001796.json","markdown":"https://secwatch.observer/filing/0001437749-24-001796.md","text":"https://secwatch.observer/filing/0001437749-24-001796.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/880242/000143774924001796/0001437749-24-001796-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/880242/000143774924001796/blgo20240121_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T20:53:40.883187+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}